BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 21, 2026
See today's BioWorld
Home
» Prothena Prices $130M Offering; Janssen to Sell All Holdings
To read the full story,
subscribe
or
sign in
.
Prothena Prices $130M Offering; Janssen to Sell All Holdings
Oct. 4, 2013
By
Catherine Shaffer
A public offering of about 5.9 million shares at $22 per share will bring in about $70.8 million in net proceeds for Prothena Corp. plc.
BioWorld